mci 154 has been researched along with Heart Failure in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwama, Y; Takagi, A | 1 |
| Ohizumi, Y | 1 |
| Katz, SD; Mathew, L | 1 |
| Duncker, DJ; Verdouw, PD | 1 |
| Brozovich, FV; Morgan, JP; Perreault, CL; Ransil, BJ | 1 |
| Goto, T; Hashimoto, H; Hosono, M; Nunoki, K; Sato, Y; Satoh, K; Taira, N | 1 |
| Kitada, Y; Narimatsu, A; Okushima, H; Satoh, N; Suzuki, R | 1 |
4 review(s) available for mci 154 and Heart Failure
| Article | Year |
|---|---|
[Calcium sensitizer agents in heart failure therapy].
Topics: Calcium; Cardiotonic Agents; Clinical Trials as Topic; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Stimulation, Chemical | 2007 |
[Tendency of development on novel type of cardiotonic drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin | 1993 |
Calcium sensitising agents in heart failure.
Topics: Aged; Animals; Calcium; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan | 1998 |
Inotropic therapy of heart failure. Editorial comments on: Vasodilation and mechanoenergetic inefficiency dominates the effect of the "Ca2+ sensitizer" MCI-154 in intact pigs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Calcium Channel Agonists; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Energy Metabolism; Heart Failure; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Pyridazines; Swine | 2002 |
3 other study(ies) available for mci 154 and Heart Failure
| Article | Year |
|---|---|
Effects of MCI-154 on Ca2+ activation of skinned human myocardium.
Topics: Calcium; Cardiotonic Agents; Heart; Heart Failure; Humans; In Vitro Techniques; Myocardium; Pyridazines | 1989 |
Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dogs; Female; Heart Failure; Heart Rate; In Vitro Techniques; Male; Pentobarbital; Pyridazines | 1988 |
Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart Failure; Hemodynamics; Hindlimb; Male; Propranolol; Pyridazines; Regional Blood Flow; Vasodilator Agents; Verapamil | 1987 |